Pharmaceutical Commerce - September 2021 Issue (PDF)

Publication
Article
Pharmaceutical CommercePharmaceutical Commerce - September 2021
Volume 16
Issue 3

Click the title above for a link to open the Pharmaceutical Commerce September 2021 issue in an interactive PDF format.

Click cover to access PDF

Download Issue PDF
Articles in this issue
supply chain
When the extreme hits home
Pharmaceutical Commerce - September 2021 Issue (PDF)
Pharmaceutical Commerce - September 2021 Issue (PDF)
Pharma Cold Chain: Pushing the Envelope
Pharma Cold Chain: Pushing the Envelope
The Temperament for Transport
The Temperament for Transport
The Opportunity for Sustainability
The Opportunity for Sustainability
Shipping Strategies in Unusual Times
Shipping Strategies in Unusual Times
New Blueprint for HCP Relationships
New Blueprint for HCP Relationships
Pharma Cold Chain
2021 Cold Chain Service Provider Directory
The True Reliability of Real-World Data
The True Reliability of Real-World Data
The Future Heats Up Due to Cold Chain
The Future Heats Up Due to Cold Chain
Related Videos
Related Content
Kühne Holding Inks Deal for Aenova

Kühne Holding Inks Deal for Aenova

April 25th 2024
Article

The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry.

Mitigating Drug Shortages

Mitigating Drug Shortages

April 12th 2024
Podcast

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

Pharma Pulse 4/25/24: Advocate for Greater Pharmacy Technician Roles, Global COVID-19 Vaccines Strategic Research Report 2024 & more

Pharma Pulse 4/25/24: Advocate for Greater Pharmacy Technician Roles, Global COVID-19 Vaccines Strategic Research Report 2024 & more

April 25th 2024
Article

The latest news for pharma industry insiders.

A Further Examination of Pharmacy Benefit Managers

A Further Examination of Pharmacy Benefit Managers

March 29th 2024
Podcast

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals for $750 Million

Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals for $750 Million

April 24th 2024
Article

Deal gives Incyte access to Escient’s pipeline of oral MRGPR antagonists, including EP262 and EP547.

Pharma Pulse 4/24/24: Migraine Treatment Comes in Different Forms, State Level Legislation Impacting Patient Services & more

Pharma Pulse 4/24/24: Migraine Treatment Comes in Different Forms, State Level Legislation Impacting Patient Services & more

April 24th 2024
Article

The latest news for pharma industry insiders.

© 2024 MJH Life Sciences

All rights reserved.